Nationwide analysis of routine clinical practices in the management of acute ischemic stroke patients in China

Our findings showed relatively low utilization rates of thrombolytic (2.76%) and interventional therapies (3.23%) in China, highlighting the urgent need to improve access to these evidence-based reperfusion strategies. The use of neuroprotective agents, Chinese herbal medicine, acupuncture, and rehabilitation might be associated with reduced in-hospital mortality in AIS patients; however, future high-quality prospective studies are still warranted to confirm the clinical effects of these treatments.